
Faculty, Staff and Student Publications
Publication Date
6-1-2023
Journal
Cancer Research Communications
Abstract
UNLABELLED: Triple-negative breast cancer (TNBC) has high relapse and metastasis rates and a high proportion of cancer stem-like cells (CSC), which possess self-renewal and tumor initiation capacity. MELK (maternal embryonic leucine zipper kinase), a protein kinase of the Snf1/AMPK kinase family, is known to promote CSC maintenance and malignant transformation. However, the role of MELK in TNBC metastasis is unknown; we sought to address this in the current study. We found that
SIGNIFICANCE: These findings indicate that MELK is a driver of aggressiveness and metastasis in TNBC.
Keywords
Humans, Animals, Mice, Triple Negative Breast Neoplasms, Mice, Nude, Leucine Zippers, Cell Proliferation, Neoplasm Recurrence, Local, Protein Serine-Threonine Kinases
DOI
10.1158/2767-9764.CRC-22-0330
PMID
37377604
PMCID
PMC10281291
PubMedCentral® Posted Date
June 2023
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Oncology Commons
Comments
This article has been corrected. See Cancer Res Commun. 2024 January; 4(1): 236.